AR010343A1 - USE OF 17 BETA-DIHYDROEKYLENINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF 17 BETA-DIHYDROEKYLENINE-3-SULPHATE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AS ANTIOXIDANT AND PHARMACEUTICAL COMPOSITION. - Google Patents

USE OF 17 BETA-DIHYDROEKYLENINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF 17 BETA-DIHYDROEKYLENINE-3-SULPHATE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AS ANTIOXIDANT AND PHARMACEUTICAL COMPOSITION.

Info

Publication number
AR010343A1
AR010343A1 ARP970105777A ARP970105777A AR010343A1 AR 010343 A1 AR010343 A1 AR 010343A1 AR P970105777 A ARP970105777 A AR P970105777A AR P970105777 A ARP970105777 A AR P970105777A AR 010343 A1 AR010343 A1 AR 010343A1
Authority
AR
Argentina
Prior art keywords
beta
dihydroekylenine
pharmaceutically acceptable
acceptable salt
manufacture
Prior art date
Application number
ARP970105777A
Other languages
Spanish (es)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR010343A1 publication Critical patent/AR010343A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un uso de 17 beta-dihidroequilenina o una sal faramcéuticamente aceptable del ester de 17 beta-dihidroequilenina-3-sulfato para la manufactura de unmedicamento que comprende una cantidad antioxidante de 17 beta- -dihidroequileninao una sal farmacéuticamente aceptable de éster de 17 beta--dihidroequilenina-3-sulfato util a un mamífero que necesite de dicho tratamiento, y un vehículo farmacéuticamente aceptable; composicionfarmacéutica.A use of 17 beta-dihydroekylene or a pharmaceutically acceptable salt of 17 beta-dihydroekylene-3-sulfate ester for the manufacture of a drug comprising an antioxidant amount of 17 beta-dihydroekylene or a pharmaceutically acceptable salt of 17 beta ester-- dihydroekylene-3-sulfate useful to a mammal in need of such treatment, and a pharmaceutically acceptable carrier; pharmaceutical composition.

ARP970105777A 1996-12-10 1997-12-09 USE OF 17 BETA-DIHYDROEKYLENINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF 17 BETA-DIHYDROEKYLENINE-3-SULPHATE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AS ANTIOXIDANT AND PHARMACEUTICAL COMPOSITION. AR010343A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76306596A 1996-12-10 1996-12-10

Publications (1)

Publication Number Publication Date
AR010343A1 true AR010343A1 (en) 2000-06-07

Family

ID=25066793

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105777A AR010343A1 (en) 1996-12-10 1997-12-09 USE OF 17 BETA-DIHYDROEKYLENINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF 17 BETA-DIHYDROEKYLENINE-3-SULPHATE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AS ANTIOXIDANT AND PHARMACEUTICAL COMPOSITION.

Country Status (13)

Country Link
EP (1) EP0944390A1 (en)
JP (1) JP2001506627A (en)
KR (1) KR20000069400A (en)
CN (1) CN1239891A (en)
AR (1) AR010343A1 (en)
AU (1) AU744098C (en)
BR (1) BR9713998A (en)
CA (1) CA2272074A1 (en)
HU (1) HUP0000476A3 (en)
IL (1) IL130070A0 (en)
TW (1) TW422693B (en)
WO (1) WO1998025625A1 (en)
ZA (1) ZA9711054B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030013692A1 (en) * 2001-01-19 2003-01-16 Gullans Steven R. Methods of treating neurological disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
IL107343A (en) * 1992-11-02 2003-10-31 Wyeth Corp PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
US5545635A (en) * 1995-05-23 1996-08-13 Eli Lilly And Company Inhibiting bone loss with equilenin
AU7013296A (en) * 1995-08-30 1997-03-19 Eli Lilly And Company N-butylsulfonate esters of estrogens

Also Published As

Publication number Publication date
ZA9711054B (en) 1999-06-09
IL130070A0 (en) 2000-02-29
BR9713998A (en) 2000-02-29
CN1239891A (en) 1999-12-29
CA2272074A1 (en) 1998-06-18
HUP0000476A2 (en) 2000-10-28
KR20000069400A (en) 2000-11-25
AU7845298A (en) 1998-07-03
AU744098B2 (en) 2002-02-14
TW422693B (en) 2001-02-21
WO1998025625A1 (en) 1998-06-18
JP2001506627A (en) 2001-05-22
HUP0000476A3 (en) 2001-01-29
AU744098C (en) 2003-07-31
EP0944390A1 (en) 1999-09-29

Similar Documents

Publication Publication Date Title
ES2159591T3 (en) COMPOSITION OF CONTROLLED RELEASE.
AR004700A1 (en) 1ALFA, 26 DIHIDROXI-D-HOMO-VITAMIN D3, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PROCEDURE FOR ITS PREPARATION AND USE OF THEM IN THE ELABORATION OF A MEDICINAL PRODUCT
GEP20002013B (en) Therapeutical Means
ECSP941104A (en) DERIVATIVES OF 2,6 DIAMINOPURINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ES2178430T3 (en) USE OF GELIFICABLE PHARMACEUTICAL COMPOSITIONS IN PARODONTOLOGY.
UY26372A1 (en) "IMIDAZO-3-IL-AMINAS BICÍCLICAS PROCEDURE FOR ITS PREPARATION AND DRUGS THAT CONTAIN THEM"
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
ES488168A0 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL OR MEDICINAL TABLETS FOR ORAL ADMINISTRATION, WITH DELAYED DELIVERY OF ACTIVE ACTIVE, IN TABLETS IN WHICH THE QUANTITY OF RELEASE OF THE ACTIVE AGENT IS DEFAULT.
CL2004001191A1 (en) COMPOUNDS DERIVED FROM STEROIDS 17 ALPHA-FLUORO RENTED, WITH ANTIGESTAGENA ACTIVITY; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE OF THE COMPOUND IN THE PREPARATION OF AN ANTIESTROGENIC MEDICINAL PRODUCT, FOR THE TREATMENT OF DISMENORREA
CL2008003938A1 (en) Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).
ES2192234T3 (en) PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING SALTS OF 2-ARILPROPIONIC ACIDS.
AR006598A1 (en) "ANTI-FUNGOUS COMPOSITIONS, ITS USE IN THE MANUFACTURE OF MEDICINES AND A PROCEDURE FOR THE PREPARATION"
ATE84032T1 (en) BENZIMIDAZOLE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
AR006401A1 (en) PIRROLOPYROLONE COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT AND IN THERAPY, PROCESSES FOR ITS PREPARATION AND INTERMEDIARY COMPOUNDS FOR SUCH PROCESSES.
DK1167354T3 (en) Racemic hypersensitivity A
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
AR043071A1 (en) USE OF MACROLIDES FOR THE TREATMENT OF CANCER AND MACULAR DEGENERATION AND A PHARMACEUTICAL COMPOSITION
IT1263840B (en) ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF CAPSULES
RS49602B (en) Pharmaceutical microspheres of valporic acid for oral administration
MX9205568A (en) PHARMACEUTICAL COMPOSITION CONTAINING AMOUNTS OF 5-AMINO-1BETA-D-RIBOFURANOSIL-IMIDAZOLE-4-CARBOXAMIDE.
AR008886A1 (en) USE OF AN H +, K + -ATPASE INHIBITOR IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF NASAL POLIPS, OF THE WIDAL SYNDROME, USE OF SUCH INHIBITOR AND A GLUCOCORTICOID FOR THE MANUFACTURE OF A PHARMACEUTICAL FORMULATION AND PHARMACEUTICAL FORMULATION
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
AR021086A1 (en) OMEGA-AMIDAS OF N-ARILSULFONIL-AMINO ACIDS, A PROCEDURE FOR THE PREPARATION, MEDICATION, USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT.
AR011437A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MIGRANES AND THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT.
AR012638A1 (en) USE OF PREGNAN-3-OL-20-ONAS FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT TO PROVIDE PROGESTATIONAL THERAPY

Legal Events

Date Code Title Description
FA Abandonment or withdrawal